Our groundbreaking plasma-based materials are designed to improve patient outcomes and reduce healthcare costs across a variety of surgical procedures.
Location: United States, Pennsylvania, Pittsburgh
Total raised: $3M
Investors 11
Show more
Funding Rounds 1
| Date | Series | Amount | Investors |
| - | - | $3M | - |
Mentions in press and media 9
| Date | Title | Description |
| 31.05.2022 | Power Moves: Apollo Neuro taps a seasoned product leader as CTO and a growing startup gets international kudos | Power Moves is a column where we chart the comings and goings of talent across the region. Got a new hire, gig or promotion? Email us: pittsburgh@technical.ly.Apollo Neuroscience names new CTO Medical device wearable startup Apollo Neurosci... |
| 20.12.2021 | Pittsburgh’s biggest VC deals of 2021: Autonomy and life sciences top the list | Though final fourth quarter and year-end data on venture capital raises and other funding won’t be fully announced until the new year, Technical.ly has kept track of the money moves in Pittsburgh. With a paltry first two quarters, 2021 is l... |
| 12.07.2017 | Carmell Therapeutics Raises $4M in Series B Funding | Carmell Therapeutics, a Pittsburgh, PA-based biotechnology company focused on developing and commercializing regenerative medicine technologies, closed a $4M Series B financing. Backers included Pittsburgh Life Sciences Greenhouse, Harbor L... |
| 11.07.2017 | Carmell Therapeutics Closes $4M Series B | Carmell Therapeutics, a biotechnology company focused on developing and commercializing regenerative medicine technologies, announced today that on June 30, 2017 it closed a $4M Series B financing that will be used to advance its first prod... |
| 11.04.2013 | “Biologically active putty” under development could help bone fractures heal quicker | In its first application, it’s being turned into an off-the-shelf bone putty to accelereate the healing of sports-related bone injuries, like the tibia fracture Kevin Ware suffered. Carmell was founded in 2007 based on technology developed ... |
| 15.04.2011 | Carmell Therapeutics raises $3M to develop blood plasma medical devices | The equity funding was revealed in a document filed with the U.S. Securities and Exchange Commission. Nine investors participated. Carmell’s products are biologically active plastics made of blood plasma to treat sports injuries to bone and... |
| 15.04.2011 | Carmell Therapeutics Closes Series A Financing | Carmell Therapeutics, a Pittsburgh, PA-based company that manufactures novel blood plasma-based biomaterials that accelerate the repair of injured tissues, has closed a Series A financing of undisclosed amount. The round was led by Harbor L... |
| - | “Biologically active putty” under development could help bone fractures heal quicker | Tiger Woods and Hines Ward are just two of the athletes who have received platelet-rich plasma therapy – a procedure where doctors take a small sample of patient’s blood, separate the platelet-rich plasma, and inject it at the site of an in... |
| - | Carmell Therapeutics raises $3M to develop blood plasma medical devices | Carmell Therapeutics, which is developing medical devices made of plastics created from blood plasma, has raised $3 million in investment funding for a series A round. The Pittsburgh-based early stage company plans to use the funding to set... |